Opioid Technology Award Presented to Prapela

October 03, 2018

Prapela's SVS solution for Neonatal Abstinence Syndrome wins $200,000 in the Ohio Opioid Technology Challenge.

The Challenge aims to identify technology-based solutions that address the opioid epidemic and create high-tech jobs at the same time.  Prapela is now eligible for the next phase of the Challenge which will award $1,000,000 to participants that make significant progress advancing their ideas into reality.

Read More

Harvard's Wyss Institute licenses infant health-promoting technology to Prapela

August 22, 2018

Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and Prapela Inc. announced that the Institute's clinically validated Stochastic Vibro-tactile Stimulation (SVS) technology will be commercialized by the startup to develop a range of devices designed to improve infant health. The announcement follows a licensing agreement between Harvard's Office of Technology Development (OTD) and Prapela.
Read More

Prapela Wins FDA Sponsored Pediatric Device Competition

November 02, 2017

The SVS Prapela baby box by Prapela was the winner of $25,000 awarded at the Fifth Annual Pediatric Device Innovation Symposium sponsored by the FDA.

Out of 98 applications, 12 finalists were chosen and half took home a prize.

Read More

Get in touch

Leave a message

Phasellus viverra nulla ut metus varius laoreet. Etiam sollicitudin, ipsum eu pulvinar rutrum, tellus ipsum laoreet sapien, quis venenatis ante odio sit amet eros. Etiam imperdiet imperdiet orci.


Stay In Touch